✦ LIBER ✦

1402 EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS: 12 MONTH RESULTS OF A RANDOMIZED, CONTROLLED STUDY IN 719DE NOVO LIVER TRANSPLANT RECIPIENTS

✍ Scribed by Nevens, F.; De Carlis, L.; Metselaar, H.; Saliba, F.; Beckebaum, S.; Jonas, S.; Sudan, D.; Fischer, L.; Fung, J.; Jiang, H.; Junge, G.; De Simone, P.

Book ID: 122936688
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 147 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(12)61413-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

180 EVEROLIMUS-BASED IMMUNOSUPPRESSION I

180 EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL

✍ Saliba, F.; Metselaar, H.J.; Beckebaum, S.; Duvoux, C.; Navasa, M.; Dong, G.; Lo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 141 KB

26 EVEROLIMUS-BASED IMMUNOSUPPRESSION PR

26 EVEROLIMUS-BASED IMMUNOSUPPRESSION PROVIDES SUPERIOR RENAL FUNCTION AND COMPARABLE EFFICACY VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMISED CONTROLLED TRIAL

✍ Nevens, F.; De Carlis, L.; Metselaar, H.J.; Kaiser, G.M.; Saliba, F.; Jonas, S.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

171 Lower Incidence of Viral Infections

171 Lower Incidence of Viral Infections with Everolimus Versus MMF in De Novo Heart Transplant Recipients: 12 Month Analysis of a Randomized Multicenter Study

✍ H. Ross; A.G. Kfoury; A. Van Bakel; G. Ewald; J. Burton; A. Andreassen; J. Segov 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Efficacy and safety of de novo or early

Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial

✍ Jacques Dantal; François Berthoux; Marie-Christine Moal; Lionel Rostaing; Christ 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 335 KB

15: Results of a 12-Month, Multicenter,

15: Results of a 12-Month, Multicenter, Randomized Trial of Everolimus with Reduced-Exposure Cyclosporine Versus MMF and Standard-Exposure Cyclosporine in De Novo Cardiac Transplant Recipients

✍ H. Lehmkuhl; U. Livi; J. Arizon; M. Viganò; C. Magelli; P. Boissonnat; G. Gerosa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Similar Efficacy and Safety of Enteric-c

✍ Jon A. Kobashigawa; Dale G. Renlund; Gino Gerosa; Luis Almenar; Howard J. Eisen; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 104 KB